Hearing Program in Primary Care
Launched by NYU LANGONE HEALTH · Jul 5, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Hearing Program in Primary Care," is looking into how to better support people with hearing loss during their visits to primary care doctors. The study aims to find out whether providing counseling on useful listening devices, like hearing aids or personal amplifiers, is more helpful than just referring patients to regular hearing specialists. Participants will be chosen at random to receive either the counseling or the traditional referral.
To be eligible for this trial, participants need to be between 21 and 914 years old, able to speak English or Spanish, and capable of giving consent to join the research. However, individuals who already use hearing aids or cochlear implants cannot participate. If you take part in this study, you can expect to receive support tailored to your hearing needs and contribute to important research that could improve care for others with similar conditions. The trial is currently recruiting participants, and anyone interested should reach out for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • speaks English or Spanish;
- • capacity to consent to research
- Exclusion Criteria:
- • • has or uses hearing aids or cochlear implants
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
David Friedmann
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported